The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1068
ISSUE1068
December 17, 1999
Temozolomide for Refractory Anaplastic Astrocytoma
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Temozolomide for Refractory Anaplastic Astrocytoma
December 17, 1999 (Issue: 1068)
Temozolomide has received accelerated approval from the FDA for oral treatment of adults with anaplastic astrocytoma that has relapsed after treatment with a nitrosourea (lomustine or carmustine) and procarbazine.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.